Gleason grading system

Definition

Prostate cancer is diagnosed after a biopsy. One or more tissue samples are taken from the prostate and examined under the microscope.

The Gleason grading system refers to how abnormal your prostate cancer cells look and how likely the cancer is to advance and spread. A lower Gleason grade means that the cancer is slower growing and not aggressive.

Alternative Names

Prostate cancer - Gleason; Adenocarcinoma prostate - Gleason; Gleason grade; Gleason score; Gleason group; Prostate cancer - 5 grade group

Gleason Score

The first step in determining the Gleason grade is to determine the Gleason score.

Higher numbers indicate a faster growing cancer that is more likely to spread.

Currently the lowest score assigned to a tumor is grade 3. Grades below 3 show normal to near normal cells. Most cancers have a Gleason score (the sum of the two most common grades) of 6 (Gleason scores of 3+3) or 7 (Gleason scores of 3+4 or 4+3).

Gleason Grading System

Sometimes, it can be hard to predict how well people will do based just on their Gleason scores alone.

A 5 Grade Group System was created to have a better way to describe how a cancer will behave and respond to treatment.

A lower group indicates a better chance for successful treatment than a higher group. A higher group means that more of the cancer cells look different from normal cells. A higher group also means that it is more likely that the tumor will spread aggressively.

Grading helps you and your doctor determine your treatment options, along with:

References

Bostwick DG, Cheng L. Neoplasms of the prostate. In: Cheng L, MacLennan GT, Bostwick DG, eds. Urologic Surgical Pathology. 4th ed. Philadelphia, PA: Elsevier; 2020:chap 9.

Epstein JI. Pathology of prostatic neoplasia. In: Partin AW, Dmochowski RR, Kavoussi LR, Peters CA, eds. Campbell-Walsh-Wein Urology. 12th ed. Philadelphia, PA: Elsevier; 2021:chap 151.

National Cancer Institute website. Prostate cancer treatment (PDQ) – health professional version. www.cancer.gov/types/prostate/hp/prostate-treatment-pdq#_2097_toc. Updated February 2, 2022. Accessed August 26, 2022.


Review Date: 4/10/2022
Reviewed By: Kelly L. Stratton, MD, FACS, Associate Professor, Department of Urology, University of Oklahoma Health Sciences Center, Oklahoma City, OK. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com